| Today's Top Story |  |  | | | Health Care & Policy | | | | - Alethia wins patent for targeted antibodies to treat cancer
Alethia Biotherapeutics was granted a U.S. patent for a cancer-treatment method that involves the use of antibodies targeting secreted clusters that play a role in epithelial-to-mesenchymal transition, a key mechanism in tumor invasion and metastasis. "The issuance of this patent broadens our intellectual property estate for the treatment of solid tumors in which sCLU induces EMT," company President and CEO Yves Cornellier said. Pharmaceutical Business Review Online (5/17)       - Researchers grow human thymus tissue using stem cells
Researchers from the University of California at San Francisco grew functioning human thymus tissue using stem cells and growth factors. Thymus tissue plays an important role in the immune system by fostering the growth of T cells. The technique has potential applications in the transplantation of stem cells, tissue and organs, according to the study in the journal Cell Stem Cell. MedicalDaily.com (5/16) | Company & Financial News | | | | Most Popular Headlines from Last Week Results based on number of times each story was clicked by readers.
- Compulsory biotech labeling would mislead consumers
 Mandatory labeling of biotech foods would only lead consumers to believe there is something wrong with the products, contrary to scientific findings that biotech foods pose no health risks, Harvard Law School professor Cass R. Sunstein writes. "Unless science can identify a legitimate concern about risks to health or the environment, the argument for compulsory GM labels rests on weak foundations," Sunstein argues. Staten Island Advance (N.Y.)/Bloomberg (5/19)  | Webcast: A Conversation with The Johns Hopkins Hospital on Lowering the Cost of Healthcare from Inside Out
Learn how The Johns Hopkins Hospital uses its Integrated Asset and Service Management solution to improve uptime to support patient care; control costs for procurement, maintenance, labor and materials; support regulatory compliance activities; and use workflow capabilities for internal controls. Watch the webcast. |
 | Hot Topics | | | | Top five news stories selected by BIO SmartBrief readers in the past week. - Results based on number of times each story was clicked by readers.
| Industrial & Environmental | | | | - Calif. cellulosic ethanol plant achieves operational milestone
Edeniq's demonstration-scale cellulosic ethanol plant in Visalia, Calif., has reached a milestone by surpassing 1,000 hours of continuous operation. The facility also met the Department of Energy's goal for operational reliability, the company said. The next step for Edeniq is to make further improvements and continue operations at the plant with the California Energy Commission's co-sponsorship. DomesticFuel.com (5/16) | News from BIO | | | | - Secure document sharing services optimized for life science organizations
ShareVault, a leading provider of highly secure and controlled document sharing solutions and virtual data rooms (VDR), has aligned with BIO to provide companies with significant discounted pricing and complimentary extra features. ShareVault's VDR platform is optimized for life science companies of all sizes and flexibly priced so that even small biotech companies can afford and benefit from its technology. The ShareVault solution is intended for due diligence required during bio-pharma partnering, licensing, fundraising, M&A, clinical study management or other applications that require secure sharing of documents with third parties. Learn more and sign up for a free trial.
| SmartQuote | | | |  | I regret nothing, says arrogance; I will regret nothing, says inexperience."
--Marie von Ebner-Eschenbach,
Austrian writer  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Friday, May 17, 2013
- Thursday, May 16, 2013
- Wednesday, May 15, 2013
- Tuesday, May 14, 2013
- Monday, May 13, 2013
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | | | | | | © 1999-2013 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment